tucatinib,olaparib,vemurafenib,larotrectinib,trastuzumab,nivolumab,regorafenib,cobimetinib,temsirolimus,sunitinib,futibatinib,pertuzumab,entrectinib,abemaciclib,palbociclib,pembrolizumab,ipilimumab,talazoparib,atezolizumab
eli lilly,astrazeneca,seagen,bms,roche,merck,bayer,pfizer,otsuka
['tapur', 'sarcoma']
are you a person with soft tissue cancer whose tumor has an abnormal cdk4 gene and your cancer has not responded to standard treatments? talk to your oncologist about s #tapur study. #cdk4 #cdk4amplification #softtissuesarcoma
Timely, trusted, compassionate doctor-approved info from @ASCO. Signup https://t.co/2KibiNRMFU

We can't answer individual medical questions.

Retweet ≠Endorsement